GENE ONLINE|News &
Eli Lilly Forays Into RNA Editing, Betting More than a Billion Dollars on ProQR’s Technology
2021-09-09
Mu COVID Variant Could Potentially Escape Immunity But Delta is Still “Most Concerning”, WHO Says
2021-09-08
BeiGene’s Brukinsa Bags Second FDA Approval, to Rival Imbruvica in Treating a Rare Cancer
2021-09-06
Poseida Presents Encouraging Preliminary Data for Autologous CAR-T Candidate Against Solid Tumors
2021-08-31
Foundation Medicine Enters Partnership With Epic to Integrate Genomic Insights into EMR Systems
2021-08-30
Years After Playing Second Fiddle to CRISPR, RNA Editing Comes Into Its Own – An Interview with Dr. Joshua Rosenthal
2021-08-25
HebaBiz Biotech Obtains FDA Clearance to Trial Cancer Drug Against Aggressive Brain Tumor
2021-08-22
